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Abstract
Background The prognosis of penetrating traumatic brain injury (pTBI) is poor yet highly variable. Current computerized tomography
(CT) severity scores are commonly not used for pTBI prognostication but may provide important clinical information in these cohorts.
Methods All consecutive pTBI patients from two large neurotrauma databases (Helsinki 1999–2015, Stockholm 2005–2014) were
included. Outcomemeasures were 6-monthmortality and unfavorable outcome (GlasgowOutcome Scale 1–3). Admission head CT
scans were assessed according to the following: Marshall CTclassification, Rotterdam CTscore, Stockholm CTscore, and Helsinki
CTscore. The discrimination (area under the receiver operating curve, AUC) and explanatory variance (pseudo-R2) of the CTscores
were assessed individually and in addition to a base model including age, motor response, and pupil responsiveness.
Results Altogether, 75 patients were included.Overall 6-monthmortality and unfavorable outcomewere 45%and 61% for all patients,
and 31% and 51% for actively treated patients. The CT scores’ AUCs and pseudo-R2s varied between 0.77–0.90 and 0.35–0.60 for
mortality prediction and between 0.85–0.89 and 0.50–0.57 for unfavorable outcome prediction. The base model showed excellent
performance for mortality (AUC 0.94, pseudo-R2 0.71) and unfavorable outcome (AUC 0.89, pseudo-R2 0.53) prediction. None of the
CT scores increased the base model’s AUC (p > 0.05) yet increased its pseudo-R2 (0.09–0.15) for unfavorable outcome prediction.
Conclusion Existing head CT scores demonstrate good-to-excellent performance in 6-month outcome prediction in pTBI pa-
tients. However, they do not add independent information to known outcome predictors, indicating that a unique score capturing
the intracranial severity in pTBI may be warranted.
Keywords Traumatic brain injury . Penetrating traumatic brain injury . Computerized tomography . Prognosis . Outcome
prediction
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Introduction
Traumatic brain injury (TBI) constitutes a leading cause of
death and long-term disability worldwide [24, 25]. Although
the majority of TBIs are blunt, civilian penetrating injuries are
increasing, especially in the USA [24], and represent a con-
siderable proportion of TBI mortality and all trauma-related
deaths [4, 20]. Compared with blunt TBIs, penetrating TBIs
(pTBI) are associated with significantly higher rates of mor-
bidity and mortality. Up to 71–90% of patients die either at the
scene of accident or during transportation [1, 12, 38, 41] and
reported inpatient mortality rates range from 22 to 84% [1, 8,
9, 11, 16, 18, 19, 28, 30, 31, 35, 38–42, 45].
Given the poor yet variable outcomes accompanying pTBI,
accurate prognostication is crucial in determining which pa-
tients are likely to benefit from aggressive therapeutic inter-
ventions. However, studies into prognostic assessments in
pTBI are scarce and not as thorough as studies on blunt TBI
[32, 34, 43]. Instead, they are often based on small or relative-
ly outdated single-center series [2, 3, 9, 10, 12, 18, 19, 28,
39–41], save some exceptions [1, 11, 26, 42].Moreover, to the
best of our knowledge, the performance of previously devel-
oped head computerized tomography (CT) classification
schemes in outcome prediction has not been assessed outside
blunt TBI cohorts [33, 36, 44].
The primary aim of this study was to assess the prognostic
performance of previously developed head CT scoring sys-
tems in a contemporary two-center cohort of patients with
civilian pTBI admitted to academic neurosurgical intensive
care units (ICU). We specifically aimed to evaluate the perfor-
mance of four head CT classification systems (Marshall CT
classification [27], Rotterdam CT score [23], Stockholm CT
score [33], Helsinki CT score [36]) in predicting 6-month
mortality and 6-month functional outcome independently
and together with known TBI outcome predictors.
Materials and methods
Study design and setting
This retrospective observational two-center study investigated
the prognostic performance of specific head CT scoring sys-
tems in civilian pTBI. Both participating centers (Töölö
Hospital of HUS-Helsinki University Hospital [HUS],
Helsinki, Finland; Karolinska University Hospital [KUH],
Stockholm, Sweden) are the only tertiary trauma centers pro-
viding specialist neurosurgical and neurointensive care in their
respective regions, encompassing a combined catchment area
population of nearly 4 million inhabitants. The healthcare sys-
tems of both countries are publicly funded, and the hospitals
are non-profit in nature, providing treatment to all citizens
regardless of socioeconomic factors or insurance status. The
treatment of pTBI in both centers adheres to treatment guide-
lines resembling those that have recently been published [17].
Study population and data collection
All patients with pTBI admitted to the neurosurgical ICU of
either HUS between 1 January 1999 and 31 December 2015
or KUH between 1 January 2005 and 31 December 2014 were
included in this study. Patients were identified from databases
that have been previously described [22, 44]. A pTBI was
defined as an injury in which a projectile penetrates the skull
and enters the intracranial space. All patients’ admission head
CT scans were reviewed to verify the diagnosis. Patients who
died prior to ICU admission and patients who were readmitted
or primarily treated at another neurosurgical center were not
considered.We further excluded patients presentingmore than
24 h after injury, and patients whose admission head CTscans
were either missing or demonstrated no intracranial penetra-
tion (Fig. 1) (SDC 1).
Patient-level data were obtained from existing TBI data-
bases, including data on patient demographics, type of weap-
on, and inflictor of injury. Both databases contain admission
characteristics according to the International Mission for
Prognosis and Analysis of Clinical Trials in TBI (IMPACT)
prognostic models [13].
Admission head CT scans were reviewed by a set of pre-
defined characteristics depicting projectile trajectory and en-
abling the computation of all four CT scores under investiga-
tion. Furthermore, each patient’s angiographic studies were
evaluated for arterial injuries when available. Two authors
(ML and RR) assessed all imaging studies in the HUS cohort
(Cohen’s κ = 0.92 [95% CI, 0.90–0.95]), and two authors (CL
and EPT) assessed all imaging studies in the KUH cohort
(Cohen’s κ = 0.90 [95% CI, 0.89–0.94]). Uncertain cases
were discussed between the authors to reach a final classifica-
tion/score.
At HUS, patients with pTBI triaged as moribund on arrival
are routinely admitted to the neurosurgical ICU for monitoring
and potential organ procurement for transplantation, even
when not receiving active neurointensive care. Therefore, pa-
tients in the HUS cohort who were assigned to a standard
treatment regimen were categorized as actively treated, and
patients admitted as unsalvageable were categorized as inac-
tively treated. At KUH, patients withheld from active treat-
ment are not admitted to the ICU, and hence all patients in the
KUH cohort were actively treated and categorized
accordingly.
Outcome variables
Primary outcome measures were 6-month all-cause mortality
and 6-month functional outcome, assessed using the Glasgow
Outcome Scale (GOS) [14]. We further report 30-day all-cause
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mortality. Dates of death were extracted from the Population
Register Centre of Finland and the Swedish Tax Agency, both
keeping records of the dates and causes of death of all Finnish
and Swedish citizens, respectively. At HUS, GOS assessments
were conducted at outpatient follow-up appointments, and at
KUH, GOS was obtained by using a structured GOS assess-
ment questionnaire or at follow-up appointments. GOS was
dichotomized into favorable outcome (GOS 4–5) and unfavor-
able outcome (GOS 1–3) in the statistical analyses.
Statistical analysis
General characteristics of the study sample are presented as
medians and interquartile ranges (IQRs) for continuous vari-
ables and as numbers and percentages for categorical variables.
Inter-group comparisons were conducted using Fisher’s exact
test (two-tailed) when analyzing categorical data. Continuous
data were tested for skewness; all data were highly skewed
and hence analyzed using either the Mann–Whitney U test or
the Kruskal–Wallis test. To counteract the increased risk of type
I error associated with multiple comparisons, a Bonferroni cor-
rection was used when appropriate.
The prognostic performance of different head CT classifi-
cation systems was assessed by determining their discrimina-
tion (using the area under the receiver operating characteristic
curve [AUC]) and explanatory variance (using the
Nagelkerke’s pseudo-R2, referred to as “pseudo-R2”).
Each CT classification system was assessed for both uni-
variate performance and independent prognostic performance
in reference to an established base model consisting of age
(continuous variable), GCSmotor score (continuous variable),
and pupil responsiveness [43]. The Marshall CT classification
and Rotterdam CT score were analyzed as categorical vari-
ables, the Rotterdam CT score being ordinal, and the
Helsinki CT score and Stockholm CT score were analyzed
as continuous variables, as has been previously suggested
[44]. Differences in AUC were compared using the DeLong
test [7].
All analyses were performed using SPSS Statistics for
Windows, version 24.0, released 2017 (IBM Corp, Armonk,
NY, USA), or RStudio® (R Foundation for Statistical
Computing, Vienna, Austria; https://www.r-project.org/).
Missing data were excluded from all analyses; no imputations
were conducted due to the small sample size. A two-tailed p
value of ≤ 0.05 was considered statistically significant.
Helsinki University Hospital
Paents with penetrang TBI admied to 
the Neuro-ICU from 1999 to 2015, N =68
Karolinska University Hospital
Paents with penetrang TBI admied to 
the Neuro-ICU from 2005 to 2014, N =18
Total study populaon,
N = 75
Excluded if,
No penetrang projecle,
N = 5
No head CT available,
N = 3
Subacute injuryⁱ,
N = 1
Included from Karolinska,
N =16
Excluded if,
No head CT available,
N = 2
Included from Helsinki,
N =59
•
•
•
•
Fig. 1 Flowchart demonstrating
the inclusion and exclusion of
patients. CT, computerized
tomography; neuro-ICU,
neurosurgical intensive care unit;
TBI, traumatic brain injury
Acta Neurochir (2019) 161:2467–2478 2469
Table 1 Patients baseline characteristics
Parameter Combined
cohort
(N = 75)
Helsinki cohort
(N = 59)
Stockholm
cohort (N = 16)
p value Active treatment
cohort (N = 59)
Inactive
treatment
cohort (N = 16)
p value
Demography
Age 41.0 (26.0–52.0) 41.0 (26.0–51.0) 42.5 (26.0–55.0) 0.637 41.0 (26.0–53.0) 41.5 (27.0–47.0) 0.796
Sex
Male 68 (91%) 54 (92%) 14 (88%) 0.637 53 (90%) 15 (94%) 1.000
Female 7 (9%) 5 (9%) 2 (13%) 6 (10%) 1 (6%)
Admission
Weapon type
Firearm 51 (68%) 40 (68%) 11 (69%) 0.129 35 (59%) 16 (100%) 0.025
Nail gun 10 (13%) 10 (17%) 0 10 (17%) 0
Sharp object 10 (13%) 7 (12%) 3 (19%) 10 (17%) 0
Other 4 (5%) 2 (3%) 2 (13%) 4 (7%) 0
Self-inflicted injurya 48 (64%) 41 (69%) 7 (44%) 0.214 37 (63%) 11 (69%) 1.000
Pre-hospital physician involvementb 51 (68%) 37 (63%) 14 (88%) 0.028 39 (66%) 12 (75%) 0.762
Inter-hospital transfer 14 (19%) 11 (19%) 3 (19%) 1.000 13 (24%) 0 0.032
Admission delay
< 1 h 18 (24%) 16 (27%) 2 (13%) 0.181 13 (22%) 5 (31%) 0.103
1–2 h 36 (48%) 25 (42%) 11 (69%) 26 (44%) 10 (63%)
>2 h 19 (25%) 17 (29%) 3 (19%) 18 (31%) 1 (6%)
Missing 2 (3%) 1 (2%) 1 (6%) 2 (3%) 0
GCS score
3–8 40 (53%) 32 (54%) 8 (50%) 0.793 24 (41%) 16 (100%) < 0.001
9–12 10 (13%) 7 (12%) 3 (19%) 10 (17%) 0
13–15 24 (32%) 19 (32%) 5 (31%) 24 (41%) 0
Missing 1 (1%) 1 (2%) 0 1 (2%) 0
GCS motor scale
1 20 (27%) 16 (27%) 4 (25%) 0.289 8 (14%) 12 (75%) < 0.001
2 10 (13%) 7 (12%) 3 (19%) 6 (10%) 4 (25%)
3 1 (1%) 0 1 (6%) 1 (2%) 0
4 8 (11%) 8 (14%) 0 8 (14%) 0
5 8 (11%) 7 (12%) 1 (6%) 8 (14%) 0
6 28 (37%) 21 (36%) 7 (44%) 28 (48%) 0
Missing 0 0 0 0 0
Pupil responsiveness
Both 37 (49%) 31 (53%) 6 (38%) 0.453 36 (61%) 1 (6%) <0.001
One 8 (11%) 7 (12%) 1 (6%) 7 (12%) 1 (6%)
None 27 (36%) 19 (32%) 8 (50%) 13 (22%) 14 (88%)
Missing 3 (4%) 2 (3%) 1 (6%) 3 (5%) 0
Hypotensiona, c 17 (23%) 13 (22%) 4 (25%) 1.000 14 (24%) 3 (19%) 1.000
Hypoxiad, e 13 (17%) 12 (20%) 1 (6%) 0.673 7 (12%) 6 (38%) 0.065
Coagulopathyf, g 8 (11%) 6 (10%) 2 (13%) 0.615 7 (12%) 1 (6%) 0.673
Radiology
Perforating 26 (35%) 22 (37%) 4 (25%) 0.555 15 (25%) 11 (69%) 0.002
Entry
Frontobasal 26 (35%) 22 (37%) 4 (25%) 0.528 20 (34%) 6 (38%) 0.062
Temporal 35 (47%) 27 (46%) 8 (50%) 25 (42%) 10 (63%)
Other 14 (19%) 10 (17%) 4 (25%) 14 (24%) 0
Exit
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Table 1 (continued)
Parameter Combined
cohort
(N = 75)
Helsinki cohort
(N = 59)
Stockholm
cohort (N = 16)
p value Active treatment
cohort (N = 59)
Inactive
treatment
cohort (N = 16)
p value
Frontobasal 7 (9%) 6 (10) 1 (6%) 0.755 5 (9%) 2 (13%) 0.004
Temporal 11 (15%) 10 (17%) 1 (6%) 5 (9%) 6 (38%)
Other 8 (11%) 6 (10%) 2 (13%) 5 (9%) 3 (19%)
Trajectory
Monohemispheric 39 (52%) 32 (54%) 7 (44%) 0.575 35 (59%) 4 (25%) 0.023
Bihemispheric 34 (45%) 27 (46%) 7 (44%) 1.000 22 (37%) 12 (75%) 0.010
Unilobar 18 (24%) 14 (24%) 4 (25%) 1.000 18 (31%) 0 0.008
Multilobar 55 (73%) 45 (76%) 10 (63%) 0.341 39 (66%) 16 (100%) 0.004
Posterior fossa 14 (19%) 7 (12%) 7 (44%) 0.008 14 (24%) 0 0.032
Transventricular 33 (44%) 28 (48%) 5 (31%) 0.273 21 (36%) 12 (75%) 0.009
In proximity to COWh 25 (33%) 20 (34%) 5 (31%) 1.000 19 (32%) 6 (38%) 0.768
Bone or projectile fragments present 65 (87%) 53 (90%) 12 (75%) 0.206 49 (83%) 16 (100%) 0.081
Basal cisterns
Normal 25 (33%) 19 (32%) 6 (38%) 0.067 25 (42%) 0 < 0.001
Compressed 36 (48%) 26 (44%) 10 (63%) 32 (54%) 4 (25%)
Obliterated 14 (19%) 14 (24%) 0 2 (3%) 12 (75%)
Midline shift
0 mm 41 (53%) 33 (56%) 7 (44%) 0.753 34 (58%) 6 (38%) 0.031
1–5 mm 10 (13%) 7 (12%) 3 (19%) 9 (15%) 1 (6%)
5–10 mm 17 (23%) 13 (22%) 4 (25%) 13 (22%) 4 (25%)
> 10 mm 8 (11%) 6 (10%) 2 (13%) 3 (5%) 5 (31%)
Mass lesion > 25 cm3 23 (31%) 18 (31%) 5 (31%) 1.000 11 (19%) 12 (75%) < 0.001
EDH 2 (3%) 0 2 (13%) 0.043 2 (3%) 0 1.000
SDH 48 (64%) 36 (61%) 12 (75%) 0.386 32 (54%) 16 (100%) < 0.001
ICH 56 (75%) 44 (75%) 12 (75%) 1.000 41 (70%) 15 (94%) 0.056
Bilateral SDH 10 (15%) 10 (17%) 1 (6%) 0.439 4 (7%) 7 (44%) 0.001
tSAH in convexities
0 mm 13 (17%) 11 (19%) 2 (13%) 0.004 13 (22%) 0 0.013
1–5 mm 15 (20%) 7 (12%) 8 (50%) 14 (24%) 1 (6%)
> 5 mm 47 (63%) 41 (70%) 6 (38%) 32 (54%) 15 (94%)
tSAH in basal cisterns
0 mm 41 (55%) 33 (56%) 8 (50%) 0.189 34 (58%) 7 (44%) 0.433
1–5 mm 9 (12%) 5 (9%) 4 (25%) 6 (10%) 3 (19%)
> 5 mm 25 (33%) 21 (36%) 4 (25%) 19 (32%) 6 (38%)
IVH 39 (52%) 33 (56%) 6 (38%) 0.261 24 (41%) 15 (94%) < 0.001
Leroux IVH score
0 36 (48%) 26 (44%) 10 (63%) 0.048 35 (59%) 1 (6%) < 0.001
1–10 23 (31%) 17 (29%) 6 (38%) 18 (31%) 5 (31%)
> 10 16 (21%) 16 (27%) 0 6 (10%) 10 (63%)
Acute hydrocephalus 19 (25%) 9 (15%) 10 (63%) <0.001 14 (24%) 5 (31%) 0.533
DAI 0 0 0 NA 0 0 NA
CTA performed 19 (25%) 17 (29%) 2 (13%) 0.330 16 (27%) 3 (19%) 0.747
DSA performed 10 (13%) 10 (17%) 0 0.107 10 (17%) 0 0.107
Confirmed arterial injury 6 (8%) 6 (10%) 0 0.331 5 (9%) 1 (6%) 1.000
Marshall CT classification
I 0 0 0 0.458 0 0 < 0.001
II 22 (29%) 16 (27%) 6 (38%) 22 (37%) 0
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Ethical considerations
The regional ethics committees in both Helsinki (123/13/03/
02/2016 TMK02 § 80) and Stockholm (2016/999-31/4),
(2018/2074-32) approved the study and waived the need for
informed consent. The study adheres to the STrengthening the
Reporting of OBservational studies in Epidemiology
(STROBE) statement (SDC 2).
Results
Study population characteristics
A total of 75 patients were included. A detailed description of
study sample characteristics is presented in Table 1. Admission
and head CTcharacteristics were similar between the two study
centers. Patient median age was 41 years and 91% of patients
were male. Altogether, 64% of injuries were self-inflicted and
68% of patients had firearm-related injuries. In total, 53% of
patients presented with a GCS score of 3–8, while 32% of
patients had an admission GCS score of 13–15 and 49% had
normal pupil responsiveness. Notably, all elderly patients (>
60 years) were male and had self-inflicted firearm-related inju-
ries (SDC 3). Moreover, patients with self-inflicted injuries
were significantly older than patients with non-self-inflicted
injury (median age 47 versus 26 years, p < 0.001) (SDC 4).
Overall, 79% of patients were actively treated. All patients
from whom active treatment was withheld had firearm-related
injuries, a GCS motor score of 1 or 2, and 88% had no pupil
responsiveness (Table 1). In patients who were actively treat-
ed, 76% underwent a debridement operation and 7%
underwent a decompressive craniectomy (SDC 5). Median
ICU length of stay was 5 days (IQR 1–10) and median hospi-
tal length of stay was 8 days (IQR 5–17) for those who re-
ceived active treatment.
Radiologically, the wound trajectory was perforating (i.e.,
including an entry and an exit wound) in 35% of patients,
bihemispheric in 45% of patients, and transventricular in
44% of patients, all of which were significantly more common
in patients with a GCS score of 3–8 (SDC 6). Frontobasal and
temporal entry regions accounted for 35% and 47% of all
injuries, respectively, with frontobasal entry sites being more
common in patients with self-inflicted injuries (SDC 4).
Moreover, patients with injuries resulting from firearms or
sharp objects had higher intracranial injury severity than those
with other modes of injury, irrespective of the CT classifica-
tion scheme applied (SDC 7).
Outcomes
In the complete cohort, unadjusted 6-month all-cause
mortality was 45% and total unfavorable outcome was
61%. In the active treatment cohort, 6-month mortality
Table 1 (continued)
Parameter Combined
cohort
(N = 75)
Helsinki cohort
(N = 59)
Stockholm
cohort (N = 16)
p value Active treatment
cohort (N = 59)
Inactive
treatment
cohort (N = 16)
p value
III 20 (27%) 18 (31%) 2 (13%) 17 (29%) 3 (19%)
IV 10 (13%) 7 (12%) 3 (19%) 9 (15%) 1 (6%)
Vor VI 23 (31%) 18 (31%) 5 (31%) 11 (19%) 12 (75%)
Rotterdam CT score
1 0 0 0 0.640 0 0 < 0.001
2 9 (12%) 6 (10%) 3 (19%) 9 (15%) 0
3 13 (17%) 10 (17%) 3 (19%) 13 (22%) 0
4 23 (31%) 19 (32%) 4 (25%) 22 (37%) 1 (6%)
5 24 (32%) 18 (31%) 6 (38%) 15 (25%) 9 (56%)
6 6 (8%) 6 (10%) 0 0 6 (38%)
Helsinki CT score 6 (3–10) 6 (3–10) 6 (3–8) 0.324 5 (2–8) 13 (10–14) < 0.001
Stockholm CT score 3.2 (2.0–4.0) 3.2 (2.0–4.0) 3.1 (1.5–4.2) 0.315 2.6 (2.0–4.0) 4.4 (4.0–5.1) < 0.001
Categorical data presented as N (%) and continuous variables presented as median (IRQ). COW, circle of Willis; CT, computerized tomography; CTA,
computerized tomography angiography; DAI, diffuse axonal injury; DSA, digital subtraction angiography; EDH, epidural hematoma; GCS, Glasgow
Coma Scale; ICH, intracerebral hematoma; IVH, intraventricular hemorrhage; SDH, subdural hematoma; tSAH, traumatic subarachnoid hemorrhage
Data missing for a = 2, b = 1, d = 8, f = 4 patients
c Systolic blood pressure < 90 mmHg at any time prior to admission
e Blood oxygen saturation < 90% at any time prior to admission
g International normalized ratio ≥ 1.5 or activated partial thromboplastin time > 36 s or thrombocyte count < 100,000 mm3
hWithin 2 cm of COW
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was 31% and total unfavorable outcome was 51%
(Table 2). There was no difference between 30-day
and 6-month mortality; all deaths occurred within the
first month after injury. Higher rates of both mortality
and unfavorable outcome were observed in elderly patients
and in patients with either self-inflicted or firearm-related in-
juries, low GCS motor scores (Fig. 2), or high intracranial
injury severity (Fig. 3). By contrast, out of patients with mild
injury (GCS 13–15), only one patient (4%) died and only five
patients (21%) were dependent (GOS 3) at 6 months post-
injury.
Prognostic performance of CT classification systems
Discrimination and overall performance measures of univari-
ate models are presented in Table 3. Generally, all CT scoring
systems demonstrated better performance in the complete co-
hort in comparison with active treatment cohort, irrespective
of the outcome dichotomization.
For 6-month mortality prediction, the Helsinki CT
score outperformed the three other models, exhibiting
an AUC of 0.90 and a pseudo-R2 of 0.60. The
differences in AUC between Helsinki CT and the other
scores were statistically significant for the Marshall CT
classification (p = 0.046) and Rotterdam CT score (p =
0.003), but not for the Stockholm CT score (p = 0.089).
For unfavorable outcome prediction, the Marshall CT clas-
sification reached an AUC of 0.89 and a pseudo-R2 of 0.57,
thus performing marginally better than the Stockholm,
Helsinki, and Rotterdam CT scores. However, the differences
in AUC between the CT scores were not statistically signifi-
cant (p > 0.05 for all).
The base model consisting of age, GCS motor score,
and pupil responsiveness demonstrated an AUC of 0.94
and a pseudo-R2 of 0.71 for 6-month mortality predic-
tion, and an AUC of 0.89 and a pseudo-R2 of 0.53 for
unfavorable outcome prediction (Table 4). None of the
CT classification schemes provided a significant increase
in AUC to the base model for mortality or unfavorable
outcome prediction (p > 0.05 for all). Still, concerning
unfavorable outcome prediction, the addition of all CT
models slightly increased the base model’s pseudo-R2
(+ 0.09–0.15 for the complete cohort and + 0.11–0.19
for the active treatment cohort).
Table 2 Patient outcomes
Complete cohort (N = 75) Active treatment cohort (N = 59)
6-month all-cause
mortalitya
6-month unfavorable
outcome*
6-month all-cause
mortalitya
6-month unfavorable
outcome*
Overall 34 (45%) 46 (61%) 18 (31%) 30 (51%)
Center subgroups
Helsinki 27 (46%) 35 (59%) 11 (26%) 19 (44%)
Stockholm 7 (44%) 11 (69%) 7 (44%) 11 (69%)
Age subgroups
≤ 40 years 14 (39%) 17 (47%) 7 (24%) 10 (35%)
41–60 years 9 (32%) 18 (64%) 3 (14%) 12 (55%)
> 60 years 11 (100%) 11 (100%) 8 (100%) 8 (100%)
Weapon subgroups
Firearm 31 (61%) 38 (75%) 15 (43%) 22 (63%)
Nail gun 1 (10%) 2 (20%) 1 (10%) 2 (20%)
Sharp object 2 (20%) 5 (50%) 2 (20%) 5 (50%)
Other 0 1 (25%) 0 1 (25%)
Self-inflicted subgroups
Yes 25 (52%) 32 (67%) 14 (38%) 21 (57%)
No 8 (32%) 12 (48%) 3 (15%) 7 (35%)
GCS subgroups
3–8 31 (78%) 34 (85%) 15 (63%) 18 (75%)
9–12 2 (20%) 6 (60%) 2 (20%) 6 (60%)
13–15 1 (4%) 5 (21%) 1 (4%) 5 (21%)
GCS, Glasgow Coma Scale; GOS, Glasgow Outcome Scale
a Identical to 30-day all-cause mortality
*Defined as GOS 1–3; missing for 4 patients; median time to follow-up for 6-month survivors was 302 days (IQR
188–388 days)
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Discussion
In this study, we assessed the prognostic performance of four
head CT scoring systems in a contemporary two-center cohort
of ICU-treated patients with civilian pTBI. In terms of out-
come, we observed a 6-month mortality rate of 31% and an
overall 6-month unfavorable outcome rate of 51%, in patients
who were actively treated. Notably, all deaths occurred within
30 days from sustaining the injury. We found that all CT
classification systems demonstrated good performance in
predicting 6-month unfavorable outcome, with no significant
difference between the individual CT scores. By contrast, for
6-month mortality prediction, the Helsinki CT score showed
slightly better performance than the other CT scores.
However, none of the tested CT scoring systems significantly
increased the discriminatory performance of the reference
model for 6-month mortality or unfavorable outcome predic-
tion, highlighting the importance of clinical characteristics in
prognosis evaluation of pTBI patients, and the possible utility
of a more tailored CT scoring system for pTBI.
Previous studies into outcomes following civilian pTBI
have demonstrated marked variation in both the scope of in-
cluded patients and, consequently, in rates of mortality and
unfavorable outcome. Generally, unselected series including
patients dying at the scene of accident or during transportation
report overall mortality rates between 91 and 97% [1, 3, 12,
41], whereas in neurosurgical cohorts, mortality ranges from
34 to 84% [1, 8, 9, 11, 16, 18, 28, 30, 31, 35, 39–42] and
unfavorable outcome from 58 to 87% [11, 12, 28, 35, 39]. In
our study, we observed a 6-month mortality rate of 31% and
an overall 6-month unfavorable outcome rate of 51%, both
among the lowest figures published to date, although 6-
month mortality increased to 45% and unfavorable outcome
to 61%when including patients who were not actively treated.
These low figures are most likely explained by the fact that we
only included patients admitted to the ICU, as prior studies
have suggested 53–77% of patients with pTBI to die before
ICU admission [10, 40]. Also, studies excluding patients dy-
ing before a head CT scan or patients considered near death
have yielded results comparable with ours, with mortality
rates between 35 and 43% [18, 21]. Moreover, our study in-
cluded a relatively low proportion of patients with firearm-
related injuries and a rather high proportion of patients with
an admission GCS score of 13–15. It is well established that
gunshot injuries carry an especially poor prognosis, a conse-
quence of high projectile energy and, as a result, a greater
degree of tissue destruction [46], while patients with injuries
caused by low-velocity projectiles and patients with high ad-
mission GCS scores have been reported to exhibit mortality
and unfavorable outcome rates as low as 18% [5]. Thus, it
appears that with current treatment selection criteria, con-
scious patients (GCS score > 8) with pTBI who reach active
neurosurgical and ICU care face a prognosis comparable with
that of patients with non-penetrating TBI [37].
To date, no studies have evaluated the prognostic perfor-
mance of existing head CT scoring systems in predicting out-
comes following pTBI. Several studies have, however,
assessed the scores’ performance in cohorts of non-
penetrating TBI patients, reporting AUCs ranging primarily
from 0.60 to 0.80 for both mortality and unfavorable outcome
prediction [6, 36, 44, 47]. For instance, Thelin and colleagues
found the Stockholm and Helsinki CT scores superior to the
more conventional Rotterdam and Marshall grading systems
(AUCs, 0.72–0.77 versus 0.58–0.68; pseudo-R2s, 0.19–0.28
versus 0.03–0.15) [44] in 1115 ICU-admitted patients with
blunt TBI, while one study noted an AUC of 0.85 for both
the Marshall CT classification and Rotterdam CT score in
Fig. 2 Spine plots illustrating the relationship between GCS motor score
(x-axis) and functional outcome (y-axis, left) for the complete cohort (a)
and the active treatment cohort (b). The right y-axis represents outcome
proportions summing to 1. On the left y-axis, dark gray represents a GOS
of 1, medium gray represents a GOS of 2 or 3, and light gray represents a
GOS of 4 or 5. The sizes of the bins correspond to the number of patients
in each category. GCS, Glasgow Coma Scale; GOS, Glasgow Outcome
Scale
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predicting in-hospital mortality [29]. However, interestingly,
all CT scores reached higher AUCs (0.77–0.90) and pseudo-
R2s (0.35–0.60) in the present study than in the blunt TBI
cohorts of prior studies, despite the scores having been origi-
nally developed for blunt TBI assessment. Although no im-
mediate explanation for this is available, it is possible that, in
penetrating injuries, intracranial destruction is more extensive,
and thus a prognostic system based on head CT features is
more feasible and better tiered than in blunt TBI where mul-
tiple injury characteristics are not as common. Moreover, the
outcome distribution in pTBI differs markedly from that of
blunt TBI—a higher proportion of patients die and less recov-
er to an unfavorable state [35]—which may, to some extent,
explain especially the Helsinki CTscore's’ performance (AUC
0.90) in mortality prediction.
Altogether, prognostic models specific for pTBI are scarce.
The only existing study found a base model of GCS motor
score and pupil responsiveness alone to reach an AUC of 0.93
[30], a finding consistent with our results. Moreover, the same
study presented a multivariable model with extremely high
discriminatory performance (AUC 0.97) without including
any head CT variables, suggesting accurate estimates may
be attainable without radiological information. Thus, together
with results from previous investigations, the present study
underscores the prognostic utility of clinical characteristics
in the setting of pTBI. Still, future studies should further ex-
plore the role of head CT data in prognosis evaluation and
seek to combine radiological information with clinical and
laboratory data, enabling the development of refined prognos-
tic models specific to pTBI.
Strengths and limitations
We included all consecutive ICU-admitted patients with pTBI
from two large academic trauma centers, responsible for pro-
viding tertiary-level care to a combined catchment area popu-
lation of approximately four million inhabitants. Thus, despite
its small sample size, we consider our study to be largely
representative of patients with pTBI necessitating neurosurgi-
cal and neurointensive care in Nordic countries. Moreover,
our study did not limit its scope to, for instance, firearm-
related or self-inflicted injuries, but instead included all modes
Fig. 3 Spine plots illustrating the relationship between CT findings (x-
axis) and functional outcome (y-axis, left) for the Marshall CT
classification (a), the Rotterdam CT score (b), the Stockholm CT score
(c), and the Helsinki CT score (d). The right y-axis represents outcome
proportions summing to 1. On the left y-axis, dark gray represents a GOS
of 1, medium gray represents a GOS of 2 or 3, and light gray represents a
GOS of 4 or 5. The sizes of the bins correspond to the number of patients
in each category. CT, computerized tomography; GOS, Glasgow
Outcome Scale
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of injury currently encountered at contemporary neurosurgical
institutions. Furthermore, in addition to mortality assessment,
we also evaluated functional outcome, an aspect of recovery
that has been overlooked by most previous studies into pTBI.
Still, certain limitations require acknowledgement. First,
we only included patients admitted to a neurosurgical ICU,
due to which our results are not generalizable to the major-
ity of patients with pTBI, most of whom die prior to ICU
admission [1, 12, 38, 41]. Second, the study’s retrospective
design resulted in missing data and compelled us to assess
functional outcome using GOS as opposed the more refined
GOS-extended [15]. Still, considering that the amount of
missing data was low and that most previous studies have
neglected the assessment of functional outcome altogether,
these shortcomings can presumably be considered as minor.
Third, although this study includes two of Northern
Europe’s largest hospitals, the study population is still rather
small, highlighting the rarity of pTBI in the Nordics.
Conclusion
Selected patients with pTBI receiving active ICU treatment
face a reasonable prognosis, comparable with that of patients
Table 3 Univariate performance
of CT models Model Complete cohort Active treatment cohort
R2 AUC (95% CI) p value R2 AUC (95% CI) p value
6-month mortality
Marshall 0.402 0.815 (0.715–0.914) 0.046 0.247 0.750 (0.612–0.888) 0.362
Rotterdam 0.348 0.774 (0.669–0.879) 0.003 0.119 0.654 (0.509–0.799) 0.037
Stockholm 0.459 0.850 (0.827–0.973) 0.089 0.287 0.783 (0.653–0.912) 0.390
Helsinki 0.601 0.900 (0.762–0.938) Ref 0.368 0.816 (0.694–0.939) Ref
6-month unfavorable outcome*
Marshall 0.574 0.887 (0.802–0.971) Ref 0.498 0.849 (0.742–0.957) Ref
Rotterdam 0.519 0.846 (0.744–0.947) 0.116 0.443 0.825 (0.710–0.941) 0.366
Stockholm 0.507 0.871 (0.776–0.967) 0.769 0.407 0.833 (0.718–0.949) 0.802
Helsinki 0.502 0.868 (0.787–0.949) 0.653 0.363 0.800 (0.685–0.915) 0.391
Differences in AUC were compared using the DeLong test. AUC, area under the curve; CI, confidence interval;
GOS, Glasgow Outcome Scale
*Defined as GOS 1–3; missing for 4 patients
Table 4 Multivariate performance of CT models
Model Complete cohort Active treatment cohort
R2 Gain in R2 AUC (95% CI) Gain in AUC p value R2 Gain in R2 AUC (95% CI) Gain in
AUC
p value
6-month mortality
Base 0.708 0.943 (0.896–0.991) 0.578 0.917 (0.847–0.987)
Base + Marshall 0.739 + 0.031 0.947 (0.902–0.992) + 0.004 0.720 0.608 + 0.030 0.911 (0.837–0.985) − 0.006 0.749
Base + Rotterdam 0.753 + 0.045 0.953 (0.911–0.995) + 0.010 0.328 0.588 + 0.010 0.914 (0.842–0.986) − 0.003 0.719
Base + Helsinki 0.792 + 0.084 0.963 (0.928–0.999) + 0.020 0.220 0.668 + 0.090 0.931 (0.868–0.993) + 0.014 0.588
Base + Stockholm 0.741 + 0.033 0.952 (0.909–0.994) + 0.009 0.410 0.611 + 0.033 0.919 (0.849–0.988) + 0.002 0.933
6-month unfavorable outcome*
Base 0.526 0.885 (0.806–0.964) 0.405 0.823 (0.709–0.937)
Base + Marshall 0.673 + 0.147 0.933 (0.876–0.990) + 0.048 0.099 0.594 + 0.189 0.898 (0.813–0.983) + 0.075 0.093
Base + Rotterdam 0.672 + 0.146 0.930 (0.869–0.992) + 0.045 0.124 0.590 + 0.185 0.892 (0.802–0.982) + 0.069 0.123
Base + Helsinki 0.619 + 0.093 0.917 (0.846–0.988) + 0.032 0.159 0.514 + 0.109 0.876 (0.771–0.980) + 0.053 0.121
Base + Stockholm 0.639 + 0.112 0.927 (0.857–0.996) + 0.042 0.130 0.545 + 0.140 0.901 (0.808–0.994) + 0.078 0.052
Differences in AUCwere compared using the DeLong test. Base model: age + GCSmotor score + pupil responsiveness. AUC, area under the curve; CI,
confidence interval; CT, computerized tomography; GOS, Glasgow Outcome Scale
*Defined as GOS 1–3; missing for 4 patients
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with non-penetrating TBI. Existing head CTclassification sys-
tems demonstrate mostly good-to-excellent statistical perfor-
mance in outcome prediction, yet do not significantly improve
the performance of a simple model based on age, motor re-
sponse, and pupil responsiveness. Further prospective multi-
center studies into outcomes and prognostic models for pTBI
are warranted.
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